AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets
AtaiBeckley to be added to the Russell 2000® Index and the broad-market…
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
July 25, 2025 16:05 ET | Source: atai Life Sciences Initial results…


